Literature DB >> 19129683

Malignancy grade-dependent expression of K+-channel subtypes in human prostate cancer.

Susumu Ohya1, Kazunori Kimura, Satomi Niwa, Akitoshi Ohno, Yoshiyuki Kojima, Shoichi Sasaki, Kenjiro Kohri, Yuji Imaizumi.   

Abstract

K(+) channels are key molecules in the progression of several cancer types and considered to be potential targets for cancer therapy. We examined the gene expressions of voltage-gated (K(v)), Ca(2+)-activated (K(Ca)), and two-pore domain (K(2P)) K(+)-channel subtypes in needle-biopsy samples of human prostate cancer (PCa) by real-time PCR and compared them with those in PCa epithelial cell lines. The expression of K(v)1.3, K(Ca)1.1, K(Ca)3.1, and K(2P)1 markedly increased in the PCa group with Gleason score of 5 - 6 (GS5-6) but significantly decreased in the GS8-9 group. This malignancy grade-dependent K(+)-channel expression pattern may provide a convenient marker to understand PCa progression level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129683     DOI: 10.1254/jphs.08208sc

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  10 in total

1.  Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.

Authors:  Jake Higgins; Michele Brogley; Nallasivam Palanisamy; Rohit Mehra; Michael M Ittmann; Jun Z Li; Scott A Tomlins; Diane M Robins
Journal:  Horm Cancer       Date:  2015-01-29       Impact factor: 3.869

2.  KCNN4 induces multiple chemoresistance in breast cancer by regulating BCL2A1.

Authors:  Peiyang Lin; Junjing Li; Fugui Ye; Wenfen Fu; Xin Hu; Zhiming Shao; Chuangui Song
Journal:  Am J Cancer Res       Date:  2020-10-01       Impact factor: 6.166

3.  Modulatory Effect of Selected Dietary Phytochemicals on Delayed Rectifier K+ Current in Human Prostate Cancer Cells.

Authors:  Kiran George; Nisha Susan Thomas; Raman Malathi
Journal:  J Membr Biol       Date:  2019-06-04       Impact factor: 1.843

4.  Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.

Authors:  Chunling Huang; Sylvie Shen; Qing Ma; Jason Chen; Anthony Gill; Carol A Pollock; Xin-Ming Chen
Journal:  Diabetes       Date:  2013-05-08       Impact factor: 9.461

5.  KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer.

Authors:  Haiyue Zhao; Ensong Guo; Ting Hu; Qian Sun; Jianli Wu; Xingguang Lin; Danfeng Luo; Chaoyang Sun; Changyu Wang; Bo Zhou; Na Li; Meng Xia; Hao Lu; Li Meng; Xiaoyan Xu; Junbo Hu; Ding Ma; Gang Chen; Tao Zhu
Journal:  Oncotarget       Date:  2016-07-12

6.  KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.

Authors:  Chunling Huang; Sylvie Shen; Qing Ma; Anthony Gill; Carol A Pollock; Xin-Ming Chen
Journal:  Nephrol Dial Transplant       Date:  2013-10-28       Impact factor: 5.992

7.  High glucose induces CCL20 in proximal tubular cells via activation of the KCa3.1 channel.

Authors:  Chunling Huang; Carol A Pollock; Xin-Ming Chen
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

8.  KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways.

Authors:  Chunling Huang; Mike Z Lin; Delfine Cheng; Filip Braet; Carol A Pollock; Xin-Ming Chen
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

9.  Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cells.

Authors:  Susumu Ohya; Saki Kanatsuka; Noriyuki Hatano; Hiroaki Kito; Azusa Matsui; Mayu Fujimoto; Sayo Matsuba; Satomi Niwa; Peng Zhan; Takayoshi Suzuki; Katsuhiko Muraki
Journal:  Pharmacol Res Perspect       Date:  2016-03-17

10.  Transcriptional Repression and Protein Degradation of the Ca2+-Activated K+ Channel KCa1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells.

Authors:  Anowara Khatun; Motoki Shimozawa; Hiroaki Kito; Mayu Kawaguchi; Mayu Fujimoto; Moe Ri; Junko Kajikuri; Satomi Niwa; Masanori Fujii; Susumu Ohya
Journal:  Front Physiol       Date:  2018-04-16       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.